Literature DB >> 25543043

Hyper-IgE syndrome with a novel STAT3 mutation-a single center study from India.

Biman Saikia1, Deepti Suri, Shubham Goel, Amit Rawat, Ranjana W Minz, Anju Gupta, Sudha Sharma, Osamu Ohara, Kohsuke Imai, Shigeaki Nonoyama, Shobha Sehgal, Surjit Singh.   

Abstract

BACKGROUND: Hyper IgE syndrome (HIES) is a rare primary immunodeficiency disorder characterized by the triad of elevated IgE and eosinophilia, eczema and recurrent skin and pulmonary infections. Mutation in the STAT3 gene accounts for majority of the autosomal dominant and sporadic forms of HIES.
OBJECTIVE: To report clinical and molecular analyses of patients with Hyper IgE syndrome from a single tertiary care center in India.
METHODS: Four patients with suspected HIES were studied. Flowcytometry for T(H)17 cell numbers and phosphoSTAT3, and STAT3 gene sequencing were performed.
RESULTS: T(H)17 cells were significantly reduced. Mutations were found in the DNA-binding domain in three and a mutation in the transactivation domain in one patient. One of the mutations detected was a novel mutation (g54792 c.1018A> C p.K340Q) in the DNA binding domain. Mycobacterial infection, which is usually not commonly associated with HIES was found in two of our cases, one with a cutaneous abscess in the shoulder, and the other with BCG site reactivation.
CONCLUSIONS: A novel mutation in the STAT3 is reported. Mycobacterial infections can be seen in the spectrum of HIES related infections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25543043     DOI: 10.12932/AP0456.32.4.2014

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  8 in total

1.  Rapid Transition of Facial Features from Early to Mid - Adolescence in Autosomal Dominant Hyper IgE Syndrome with a STAT3 Variation.

Authors:  A Riyaz; C Krishnan; Vinod Scaria
Journal:  Indian J Pediatr       Date:  2018-01-24       Impact factor: 1.967

Review 2.  The Ying and Yang of STAT3 in Human Disease.

Authors:  Tiphanie P Vogel; Joshua D Milner; Megan A Cooper
Journal:  J Clin Immunol       Date:  2015-08-18       Impact factor: 8.317

3.  Eosinophilia in an Acutely Limping Child: An Easy Guess of Rare Systemic Aetiology!

Authors:  Harshita Sharma; Santosh Venketraman Kondekar; Maaz Ahmed; Surbhi Rathi
Journal:  J Clin Diagn Res       Date:  2016-06-01

4.  TH17 Cells in STAT3 Related Hyper-IgE Syndrome.

Authors:  Sudha Sharma; Biman Saikia; Shubham Goel; Amit Rawat; Ranjana W Minz; Deepti Suri; Seema Chhabra; Surjit Singh
Journal:  Indian J Pediatr       Date:  2016-05-26       Impact factor: 1.967

Review 5.  Primary immunodeficiencies associated with eosinophilia.

Authors:  Behdad Navabi; Julia Elizabeth Mainwaring Upton
Journal:  Allergy Asthma Clin Immunol       Date:  2016-05-24       Impact factor: 3.406

6.  Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?

Authors:  Rajiva de Silva; Dhanushka Dasanayake; Manouri Senanayake; Ramya Ediriweera; Savithri Dias; Chandima Karunatilleke; Karen Brocas; Fariba Tahami; Suranjith Seneviratne
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-02       Impact factor: 3.406

7.  Clinical Profile of Hyper-IgE Syndrome in India.

Authors:  Biman Saikia; Amit Rawat; Ranjana W Minz; Deepti Suri; Vignesh Pandiarajan; Ankur Jindal; Smrity Sahu; Adil Karim; Mukesh Desai; Prasad D Taur; Ambreen Pandrowala; Vijaya Gowri; Manisha Madkaikar; Aparna Dalvi; Reetika Mallik Yadav; Harsha Prasada Lashkari; Revathi Raj; Ramya Uppuluri; Venkateswaran V Swaminathan; Sagar Bhattad; Gladys Cyril; Harish Kumar; Anuj Shukla; Manas Kalra; Geeta Govindaraj; Surjit Singh
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

8.  STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome.

Authors:  Shubham Goel; Smrity Sahu; Ranjana W Minz; Surjit Singh; Deepti Suri; Young M Oh; Amit Rawat; Shobha Sehgal; Biman Saikia
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.